APA (7th ed.) Citation

RS, P., MJ, M., HE, G., L, H., S, D., RT, R., . . . MP, M. (2024). Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study. European journal of clinical investigation, 54 Suppl 2, e14344. https://doi.org/10.1111/eci.14344

Chicago Style (17th ed.) Citation

RS, Patarrão, et al. "Insights into Circulating CEACAM1 in Insulin Clearance and Disease Progression: Evidence from the Portuguese PREVADIAB2 Study." European Journal of Clinical Investigation 54 Suppl 2 (2024): e14344. https://doi.org/10.1111/eci.14344.

MLA (9th ed.) Citation

RS, Patarrão, et al. "Insights into Circulating CEACAM1 in Insulin Clearance and Disease Progression: Evidence from the Portuguese PREVADIAB2 Study." European Journal of Clinical Investigation, vol. 54 Suppl 2, 2024, p. e14344, https://doi.org/10.1111/eci.14344.